Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Strategic Advisory Board
PR Newswire —
Strategic Advisory Leadership expands as Immorta Bio Advances Radical Life Extension Therapies toward the clinic MIAMI, Feb. 3, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company focused on Treating Diseases of Aging and Treating Aging as Disease™, today announced the...